Tumour‐associated leucocytes: Friends or foes in breast carcinoma

The Journal of Pathology

Volumn 172, Issue 3, 1994, Pages 229-235

  O'Sullivan, Colette ^a   Lewis, Claire E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; PRIORITY JOURNAL; REVIEW;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HLA ANTIGENS; HUMAN; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; T-LYMPHOCYTES;

EID: 0028199166     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711720302     Document Type: Review

References (36)

1. Human tumor‐infiltrating lymphocytes and their characterisation
2. Phenotypic characterization of macrophage subpopulations and localisation of Factor XIII in the stromal cells of carcinomas
3. ‘Macrophages’ and their putative significance in breast cancer
4. Secretion of epidermal growth factor by macrophages associated with breast carcinoma
5. Patterns of tumor‐infiltrating lymphocytes in 120 human cancers
6. Functional properties of tumor‐infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes
7. + monocytic cells in the tumor stroma
8. + macrophages in antitumor cytotoxicity
9. Phenotypic analysis of tumor‐infiltrating lymphocytes from human breast cancer
10. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies
11. Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas—correlation with tumour differentiation
12. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast
13. Characterisation and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast
14. Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions
15. Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte‐conditioned medium: detection of T4 antigen and its presence on normal blood lymphocytes
16. Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival
17. The origin and function of tumour‐associated macrophages
18. Macrophages in human breast disease: a quantitative immunohistochemical study
19. Prognostic significance of HER‐2/ NEU expression in breast cancer and its relationship to other prognostic factors
20. Lymphocyte infiltrates as a prognostic variable in female breast cancer
21. Pathological prognostic factors in stage I (T1NOMO) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow‐up of 18 years
22. Peripheral blood lymphocytes from patients with cancer lack interleukin‐2 receptors
23. Functional characterisation of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancer
24. Characterisation of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion
25. Clonal and frequency analyses of tumor‐infiltrating T lymphocytes from human solid tumors
26. Variable natural killer function of tumour‐infiltrating lymphocytes from breast carcinomas
27. Cytokines in neoplasia
28. Human tumour‐associated NK cells secrete increased amounts of interferon‐y and interleukin‐4
29. Expression of mRNA for cytokines in tumor‐infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer
30. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro
31. Solid tumours and wounds: transformed cells misunderstood as injured tissue?
32. A new approach to the adoptive immunotherapy of cancer with tumor‐infiltrating cells
33. Immunotherapy of patients with advanced cancer using tumor‐infiltrating lymphocytes and recombinant interleukin‐2: a pilot study
34. The basic science of gene therapy
35. Immunotherapy and gene therapy of cancer